Amanda Clarke

6.4k total citations
51 papers, 902 citations indexed

About

Amanda Clarke is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Amanda Clarke has authored 51 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 20 papers in Epidemiology and 17 papers in Virology. Recurrent topics in Amanda Clarke's work include HIV/AIDS Research and Interventions (39 papers), HIV/AIDS drug development and treatment (18 papers) and HIV Research and Treatment (17 papers). Amanda Clarke is often cited by papers focused on HIV/AIDS Research and Interventions (39 papers), HIV/AIDS drug development and treatment (18 papers) and HIV Research and Treatment (17 papers). Amanda Clarke collaborates with scholars based in United Kingdom, United States and France. Amanda Clarke's co-authors include Alison Rodger, Fiona Lampe, Andrew Phillips, Richard Gilson, Nneka Nwokolo, Janey Sewell, David Asboe, Andrew Speakman, Ada Miltz and Valentina Cambiano and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and PLoS Medicine.

In The Last Decade

Amanda Clarke

47 papers receiving 891 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Clarke United Kingdom 16 698 476 236 177 177 51 902
Paul Sereda Canada 20 824 1.2× 701 1.5× 125 0.5× 256 1.4× 136 0.8× 85 1.1k
Laurie Linley United States 12 702 1.0× 482 1.0× 218 0.9× 151 0.9× 99 0.6× 20 875
Marie S. Morgan 8 664 1.0× 443 0.9× 142 0.6× 168 0.9× 93 0.5× 8 860
John Weiser United States 16 468 0.7× 424 0.9× 152 0.6× 52 0.3× 97 0.5× 49 737
Panagiotis Vagenas United States 14 488 0.7× 468 1.0× 146 0.6× 160 0.9× 70 0.4× 26 686
Catalina Ramirez United States 13 472 0.7× 295 0.6× 91 0.4× 149 0.8× 120 0.7× 50 795
F. L. Altice United States 10 500 0.7× 527 1.1× 108 0.5× 206 1.2× 64 0.4× 16 770
Hongyan Lu China 21 940 1.3× 770 1.6× 241 1.0× 297 1.7× 37 0.2× 61 1.2k
Jonathan Colasanti United States 15 614 0.9× 475 1.0× 198 0.8× 59 0.3× 115 0.6× 69 897
Julia Hidalgo United States 13 534 0.8× 376 0.8× 126 0.5× 84 0.5× 59 0.3× 28 724

Countries citing papers authored by Amanda Clarke

Since Specialization
Citations

This map shows the geographic impact of Amanda Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Clarke more than expected).

Fields of papers citing papers by Amanda Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Clarke. The network helps show where Amanda Clarke may publish in the future.

Co-authorship network of co-authors of Amanda Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Clarke. A scholar is included among the top collaborators of Amanda Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Clarke. Amanda Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Kumar, Princy, Amanda Clarke, Miguel García Deltoro, et al.. (2024). Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study. AIDS and Behavior. 29(1). 235–245.
3.
Ko, Stephanie Q, Lourdes Domínguez, Lucy Campbell, et al.. (2024). Cardiovascular disease risk in people of African ancestry with HIV in the United Kingdom. HIV Medicine. 25(12). 1289–1297. 1 indexed citations
4.
Hart, Melanie, Mark Gompels, Alan Winston, et al.. (2023). Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial. Viruses. 16(1). 2–2.
5.
Hammond, Robert, Valentina Cambiano, Fiona Lampe, et al.. (2023). Predictors of starting and stopping chemsex in men who have sex with men in England: findings from the AURAH2 prospective study. Sexually Transmitted Infections. 99(7). 474–481. 5 indexed citations
6.
Horne, Robert, Will Nutland, Sonali Wayal, et al.. (2022). Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in England. AIDS and Behavior. 26(8). 2768–2782. 13 indexed citations
7.
Fox, Julie, Ming Lee, Achyuta Nori, et al.. (2022). Self-start HIV postexposure prophylaxis (PEPSE), to reduce time to first dose and increase efficacy. Sexually Transmitted Infections. 99(6). 367–372. 8 indexed citations
8.
9.
Hung, Rachel, Lucy Campbell, Kate Bramham, et al.. (2021). The epidemiology of kidney disease in people of African ancestry with HIV in the UK. EClinicalMedicine. 38. 101006–101006. 15 indexed citations
10.
Sewell, Janey, Valentina Cambiano, Andrew Speakman, et al.. (2019). Changes in chemsex and sexual behaviour over time, among a cohort of MSM in London and Brighton: Findings from the AURAH2 study. International Journal of Drug Policy. 68. 54–61. 77 indexed citations
11.
Ys, Kim, Shinichi Oka, Ploenchan Chetchotisakd, et al.. (2019). Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in Asian participants with human immunodeficiency virus 1 infection: A sub-analysis of phase 3 clinical trials. SHILAP Revista de lepidopterología. 20(3). 73–81. 9 indexed citations
12.
Miltz, Ada, Fiona Lampe, Sheena McCormack, et al.. (2019). Prevalence and correlates of depressive symptoms among gay, bisexual and other men who have sex with men in the PROUD randomised clinical trial of HIV pre-exposure prophylaxis. BMJ Open. 9(12). e031085–e031085. 8 indexed citations
13.
Haddow, Lewis, Claudia Godi, Magdalena Sokolska, et al.. (2018). Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus–positive Patients Treated With Protease Inhibitor Monotherapy. Clinical Infectious Diseases. 68(6). 1031–1040. 2 indexed citations
14.
Sewell, Janey, Ada Miltz, Fiona Lampe, et al.. (2017). Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics. International Journal of Drug Policy. 43. 33–43. 166 indexed citations
15.
Gourlay, Annabelle, Julie Fox, Mitzy Gafos, et al.. (2017). A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England. BMJ Open. 7(8). e016494–e016494. 14 indexed citations
16.
Sullivan, Ann, Charles Lacey, Ellen White, et al.. (2017). O03 Impact of prep on sexual behaviour? significantly lower rate of rectal ct in non-prep users in the deferred phase of proud disappeared when everyone had access to prep. Sexually Transmitted Infections. 93(Suppl 1). A1.3–A2. 1 indexed citations
17.
Sewell, Janey, Andrew Speakman, Andrew Phillips, et al.. (2016). Attitudes to and Understanding of Risk of Acquisition of HIV Over Time: Design and Methods for an Internet-based Prospective Cohort Study Among UK Men Who Have Sex With Men (the AURAH2 Study). JMIR Research Protocols. 5(2). e128–e128. 7 indexed citations
18.
Post, Frank A., Pablo Tebas, Amanda Clarke, et al.. (2016). Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(2). 180–184. 53 indexed citations
19.
20.
Gafos, Mitzy, David Dolling, Monica Desai, et al.. (2014). Sexual Behaviour Profile of Gay and Other Men Who Have Sex with Men Enrolled in the PROUD Pre-exposure Prophylaxis Open-label Pilot Study in England. AIDS Research and Human Retroviruses. 30(S1). A22–A22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Sereda Breakdown of academic impact, for papers by Laurie Linley Breakdown of academic impact, for papers by Marie S. Morgan Breakdown of academic impact, for papers by John Weiser Breakdown of academic impact, for papers by Panagiotis Vagenas Breakdown of academic impact, for papers by Catalina Ramirez Breakdown of academic impact, for papers by F. L. Altice Breakdown of academic impact, for papers by Hongyan Lu Breakdown of academic impact, for papers by Jonathan Colasanti Breakdown of academic impact, for papers by Julia Hidalgo
Rankless by CCL
2026